Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei-Yin C Polley

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinical Trials (London, England)|August 5, 2017
Power estimation in biomarker studies where events are already observedMei-Yin C Polley
Journal of the National Cancer Institute|March 31, 2021
On the Quest of Risk Stratification in HER2-Positive Breast CancerMei-Yin C Polley
Statistics in Medicine|May 19, 2011
Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicitiesMei-Yin C Polley
Statistics in Biopharmaceutical Research|May 23, 2022
Two-Stage Adaptive Design for Prognostic Biomarker Signatures with a Survival EndpointBiyue Dai, Mei-Yin C Polley
JCO Precision Oncology|September 14, 2020
Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision OncologyMei-Yin C Polley, Ying Kuen Cheung
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Statistical Considerations in the Evaluation of Continuous BiomarkersMei-Yin C Polley, James J Dignam
Clinical Trials (London, England)|September 4, 2013
Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utilityLisa M McShane, Mei-Yin C Polley
JCO Precision Oncology|September 14, 2020
Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker EvaluationMei-Yin C Polley, Edward L Korn, Boris Freidlin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 11, 2023
Molecular Profiling in Neuro-Oncology: Where We Are, Where We're Heading, and How We Ensure Everyone Can Come AlongAlyx B Porter, Patrick Y Wen, Mei-Yin C Polley
Neuro-Oncology|January 23, 2024
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perilsMei-Yin C Polley, Daniel Schwartz, Theodore Karrison, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Trials (London, England)|August 5, 2017
Power estimation in biomarker studies where events are already observedMei-Yin C Polley
Journal of the National Cancer Institute|March 31, 2021
On the Quest of Risk Stratification in HER2-Positive Breast CancerMei-Yin C Polley
Statistics in Medicine|May 19, 2011
Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicitiesMei-Yin C Polley
Statistics in Biopharmaceutical Research|May 23, 2022
Two-Stage Adaptive Design for Prognostic Biomarker Signatures with a Survival EndpointBiyue Dai, Mei-Yin C Polley
JCO Precision Oncology|September 14, 2020
Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision OncologyMei-Yin C Polley, Ying Kuen Cheung
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Statistical Considerations in the Evaluation of Continuous BiomarkersMei-Yin C Polley, James J Dignam
Clinical Trials (London, England)|September 4, 2013
Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utilityLisa M McShane, Mei-Yin C Polley
JCO Precision Oncology|September 14, 2020
Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker EvaluationMei-Yin C Polley, Edward L Korn, Boris Freidlin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 11, 2023
Molecular Profiling in Neuro-Oncology: Where We Are, Where We're Heading, and How We Ensure Everyone Can Come AlongAlyx B Porter, Patrick Y Wen, Mei-Yin C Polley
Neuro-Oncology|January 23, 2024
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perilsMei-Yin C Polley, Daniel Schwartz, Theodore Karrison, et al.
Pageof 5